Skip to main content

Current Enzyme Inhibition aims to publish all the latest and outstanding developments in enzyme inhibition studies with regards to the mechanisms of inhibitory processes of enzymes, recognition of active sites, and the discovery of agonists and antagonists, leading to the design and development of new drugs of significant therapeutic value. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a range of enzymes that can be exploited for drug development. Current Enzyme Inhibition is an essential journal for every pharmaceutical and medicinal chemist who wishes to have up-to-date knowledge about each and every development in the study of enzyme inhibition.

Publisher: Bentham Science Publishers

Volume 1, Number 2, June 2005

Review article

iNOS/COX-2 Pathway Interaction: A Good Molecular Target for Cancer Treatment
pp. 97-105(9)
Authors: Cianchi, F.; Perna, F.; Masini, E.

Favourites:
ADD

Cellular and Biochemical Alterations Caused by Artificial Depletion of Glutathione
pp. 123-130(8)
Authors: Talamoni, N. T. d.; Marchionatti, A.; Barboza, G. Diaz de; Perez, A.

Favourites:
ADD

Arachidonic Acid Cascade Enzyme Inhibition and Cancer
pp. 131-145(15)
Author: Moreno, J. J.

Favourites:
ADD
Favourites:
ADD

Proteolytic Enzymes and Their Inhibition in Epithelial Ovarian Cancer
pp. 157-170(14)
Authors: Smedts, A. M.; Curry Jr., T. E.; Murdoch, W. J.

Favourites:
ADD

The Dilemma of Modern Functional Enzymology
pp. 171-181(11)
Authors: Kettner, Carsten; Hicks, Martin G.

Favourites:
ADD

Inhibitors of Protein Prenylation: An Overview
pp. 183-206(24)
Authors: Banerjee, Saswati; McGeady, Paul

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more